Wells Fargo & Company Sol Gel Technologies Ltd. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Wells Fargo & Company holds 500 shares of SLGL stock, worth $325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$325
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SLGL
# of Institutions
22Shares Held
7.34MCall Options Held
5.4KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L32.47MShares$1.61 Million0.04% of portfolio
-
Armistice Capital, LLC New York, NY2.03MShares$1.32 Million0.02% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$797,9060.02% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$598,2160.02% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3229KShares$148,9650.04% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $15M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...